Cancer







HER2-Positive Breast Cancer

The key of abemaciclib, fulvestrant, and trastuzumab revealed a significant rise in progression-free survival (PFS) versus standard-of-care chemotherapy plus trastuzumab while giving a tolerable safety…


Heart Illness And Lab Tests

According to the new study, biomarkers that signal whether a patient’s cancer therapy may be hurting their heart have been known. Through the use of…